Abstract
BackgroundAcute myeloid leukemia (AML) is the most common acute leukemia in adults and the treatment of AML, especially monocytic AML subtypes still has a poor outcome. Therapies targeting CD33 and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have